Markers of vitamin B6 status and metabolism as predictors of incident cancer: The Hordaland Health Study

International Journal of Cancer

Volumn 136, Issue 12, 2015, Pages 2932-2939

  Zuo, Hui ^a   Ueland, Per M ^a,b   Eussen, Simone J P M ^a,c   Tell, Grethe S ^a   Vollset, Stein E ^a,d   Nygård, Ottar ^a,b   Midttun, Øivind ^e   Meyer, Klaus ^e   Ulvik, Arve ^e  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e BEVITAL AS   (Norway)

Author keywords

cancer; inflammation; metabolism; risk; vitamin B6

Indexed keywords

3 HYDROXYKYNURENINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXIC ACID; XANTHURENIC ACID; 3-HYDROXYKYNURENINE; BIOLOGICAL MARKER; KYNURENINE; PYRIDOXINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CARCINOGENESIS; COHORT ANALYSIS; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; NORWAY; NUTRITIONAL STATUS; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; ANALOGS AND DERIVATIVES; BLOOD; HEALTH SURVEY; INCIDENCE; METABOLISM; MULTIVARIATE ANALYSIS; NEOPLASMS; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGED; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; INCIDENCE; KYNURENINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASMS; NORWAY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PYRIDOXAL PHOSPHATE; PYRIDOXIC ACID; RISK ASSESSMENT; RISK FACTORS; VITAMIN B 6; XANTHURENATES;

EID: 84927537869     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29345     Document Type: Article

References (34)

1. Choi SW, Friso S,. Vitamins B6 and cancer. Subcell Biochem 2012; 56: 247-64.
2. Percudani R, Peracchi A,. A genomic overview of pyridoxal-phosphate-dependent enzymes. EMBO Rep 2003; 4: 850-4.
3. Berdanier CD, Adkins TK., Advanced nutrition, vol. 2, Micronutrients ed. Boca Raton: CRC Press, 1998. 1.
4. Paul L, Ueland PM, Selhub J,. Mechanistic perspective on the relationship between pyridoxal 5′-phosphate and inflammation. Nutr Rev 2013; 71: 239-44.
5. Ulvik A, Midttun O, Pedersen ER, et al. Association of plasma B-6 vitamers with systemic markers of inflammation before and after pyridoxine treatment in patients with stable angina pectoris. Am J Clin Nutr 2012; 95: 1072-8.
6. Johansson M, Relton C, Ueland PM, et al. Serum B vitamin levels and risk of lung cancer. JAMA 2010; 303: 2377-85.
7. Wu W, Kang S, Zhang D,. Association of vitamin B6, vitamin B12 and methionine with risk of breast cancer: a dose-response meta-analysis. Br J Cancer 2013; 109: 1926-44.
8. Eussen SJ, Vollset SE, Hustad S, et al. Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prevent 2010; 19: 2549-61.
9. Ebbing M, Bonaa KH, Nygard O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009; 302: 2119-26.
10. Martinez ME, Jacobs ET, Baron JA, et al. Dietary supplements and cancer prevention: balancing potential benefits against proven harms. J Natl Cancer Inst 2012; 104: 732-9.
11. Ulvik A, Theofylaktopoulou D, Midttun O, et al. Substrate product ratios of enzymes in the kynurenine pathway measured in plasma as indicators of functional vitamin B-6 status. Am J Clin Nutr 2013; 98: 934-40.
12. Ulvik A, Midttun O, Pedersen ER, et al. Evidence for increased catabolism of vitamin B-6 during systemic inflammation. Am J Clin Nutr 2014; 100: 250-5.
13. Sakakeeny L, Roubenoff R, Obin M, et al. Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of US adults. J Nutr 2012; 142: 1280-5.
14. Shen J, Lai CQ, Mattei J, et al. Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr 2010; 91: 337-42.
15. Christensen MH, Pedersen EK, Nordbo Y, et al. Vitamin B6 status and interferon-gamma-mediated immune activation in primary hyperparathyroidism. J Inter Med 2012; 272: 583-91.
16. Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009; 30: 1073-81.
17. Vikse BE, Vollset SE, Tell GS, et al. Distribution and determinants of serum creatinine in the general population: the Hordaland Health Study. Scand J Clin Lab Investig 2004; 64: 709-22.
18. Refsum H, Nurk E, Smith AD, et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr 2006; 136: 1731S-40S.
19. Midttun O, Hustad S, Ueland PM,. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrometr 2009; 23: 1371-9.
20. Midttun O, Kvalheim G, Ueland PM,. High-throughput, low-volume, multianalyte quantification of plasma metabolites related to one-carbon metabolism using HPLC-MS/MS. Anal Bioanal Chem 2013; 405: 2009-17.
21. Meyer K, Ueland PM,. Targeted quantification of C-reactive protein and cystatin c and its variants by immuno-MALDI-MS. Anal Chem 2014; 86: 5807-14.
22. Fritz A,. International classification of diseases for oncology: ICD-O, 3rd ed, vol. 7. Geneva: World Health Organization, 2000. 240.
23. Andersen LF, Solvoll K, Johansson LR, et al. Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol 1999; 150: 75-87.
24. Andersen LF, Veierod MB, Johansson L, et al. Evaluation of three dietary assessment methods and serum biomarkers as measures of fruit and vegetable intake, using the method of triads. Br J Nutr 2005; 93: 519-27.
25. Hess KR,. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 1995; 14: 1707-23.
26. Mantovani A, Garlanda C, Allavena P,. Molecular pathways and targets in cancer-related inflammation. Ann Med 2010; 42: 161-70.
27. Elinav E, Nowarski R, Thaiss CA, et al. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013; 13: 759-71.
28. Grivennikov SI, Greten FR, Karin M,. Immunity, inflammation, and cancer. Cell 2010; 140: 883-99.
29. Federico A, Morgillo F, Tuccillo C, et al. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer J Int Cancer 2007; 121: 2381-6.
30. Proctor MJ, Talwar D, Balmar SM, et al. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer 2010; 103: 870-6.
31. Sardesai VM., Introduction to clinical nutrition. Boca Raton, FL: CRC Press, 2011. 704.
32. Liang D, Shi Y,. Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma. Med Oncol 2012; 29: 633-9.
33. Walser T, Cui X, Yanagawa J, et al Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc 2008; 5: 811-5.
34. Morris MS, Picciano MF, Jacques PF, et al. Plasma pyridoxal 5′-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr 2008; 87: 1446-54.